• Latest Posts

Roche announces influenza drug approval and new COVID test

EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls

Roche Confirms Pharma Appetite for Inflammatory Disease Treatments

European Project Launches to Tailor Autoimmune Disease Treatments

Interview 23 May 2019

Why Clinical Trial Design Can Make or Break Your Company

AI Drug Discovery Company Raises €23M and Signs with Roche

In Depth 9 Apr 2018

Are PD-1 and PD-L1 Checkpoint Inhibitors As Good As We Thought?

Danish Biotech Starts Phase III Atopic Dermatitis Trial With Failed Asthma Treatment

Like Finding a Needle in a Haystack: How Are Biotechs Fighting Rare Diseases?

Abcam Will Start Selling Over 700 Antibodies from Roche

Actelion Spin Out and Roche Join Forces to Develop Cancer Immunotherapies

Belgian Biotech and Roche Take on Neurological and Developmental Disorders